Table 2 Treatment planning objectives
Structure | Parameter | Objective | Priority |
|---|---|---|---|
PTVboost | Prescribed dose | 69.12 Gy (32 * 2.16 Gy) | |
V99% | > 95% of prescribed dose (= 65.66 Gy) | High | |
D107% | < 2 cm3 | High | |
PTVelective | Prescribed dose | 56 Gy (32 * 1.75 Gy) | |
V99% | > 95% of prescribed dose (= 53.2 Gy) | High | |
Spinal Cord | Dmax | < 50 Gy | High |
Brainstem | Dmax | < 54 Gy | High |
Parotid glands | Dmean | Preferably < 25 Gy | High-Medium |
For at least the contralateral gland | |||
Submandibular glands | Dmean | Preferably < 25 Gy | Medium |
Oral cavity | Dmean | Preferably < 25 Gy | Medium |
Larynx | Dmean | Preferably < 45 Gy | Medium-Low |
Pharyngeal constrictors | Dmean | Preferably < 45 Gy | Medium-Low |
Other OARs | Low |